Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTERPARFUMS INC Board/Management Information 2014

Jan 8, 2014

31321_rns_2014-01-08_9a53f2a3-0b33-45c8-a61a-10c317feadc0.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 ip8k010814.htm IPAR_SERGE_ROSINOER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 8, 2014

Inter Parfums , Inc. (Exact name of Registrant as specified in its charter)

Delaware 0-16469 13-3275609
(State
or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, New York 10176 (Address of Principal Executive Offices)

212. 983.2640 (Registrant's Telephone number, including area code)

______________ (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 3.01(b).

On January 8, 2014 Inter Parfums, Inc. was advised that one of its directors, Serge Rosinoer, passed away, and on the same day notified Nasdaq OMX of such event. As the result of the death of Mr. Rosinoer, Inter Parfums, Inc. would not be in compliance with the requirement of the majority of independent directors rule, Nasdaq Rule 5605(b)(1). Inter Parfums, Inc. intends to comply with the cure period stated in Rule 5605(b)(1)(A), to have a majority of independent directors by the earlier of one year or its next annual meeting of stockholders.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: January 8, 2014

Inter Parfums, Inc. By: /s/ Russell Greenberg Russell Greenberg, Executive Vice President and Chief Financial Officer